Cognex (Tacrine)
Friday November 25, 2005
Just over a decade since its approval as a medication for Alzheimer's disease, Cognex begins to show its age and is now one of the least attractive treatment options. So why is Cognex out of favor?
From Carrie Hill, PhD, for About.com
©2009 About.com, a part of The New York Times Company.
All rights reserved.
Comments
No comments yet. Leave a Comment